Načítá se...
Delayed Treatment of 6-Bromoindirubin-3′-oxime Stimulates Neurogenesis and Functional Recovery after Focal Ischemic Stroke in Mice
Glycogen synthase kinase 3β (GSK3β) was originally identified as a regulator for glycogen metabolism and is now an important therapeutic target for a variety of brain disorders including neurodegenerative diseases due to it’s pivotal role in cellular metabolism, proliferation and differentiation. In...
Uloženo v:
| Vydáno v: | Int J Dev Neurosci |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344848/ https://ncbi.nlm.nih.gov/pubmed/28111255 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijdevneu.2017.01.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|